Hoth Therapeutics Partners With OnTargetX to Advance HT-KIT Cancer Therapy
February 12, 2025
Hoth Therapeutics, a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, announced its collaboration with OnTargetx R&D Inc. to advance research for its cancer-fighting